Abstract
The SDF1-3’ G801A (rs 1801157) polymorphism is associated with increased risk of various types of cancers, including those of the neck and head. Using PCR-RFLPs, we investigated the distribution of SDF1-3′ G801A genotypes in patients with laryngeal cancer (n = 118) and controls (n = 250) in Poland. We found that patients with SDF1-3’ A/A and G/A genotypes exhibit a 1.863-fold increased risk of laryngeal cancer (95% CI = 1.177–2.949, p = 0.0086). However, there was no significant increase in risk for the homozygous SDF1-3’ A/A genotype OR = 3.235 (95% CI = 0.5330−19.633, p = 0.3329). We also did not observe a significant association between tumor characteristics and prevalence of alleles or genotypes for the SDF1-3′ G801A polymorphism. Our findings suggest that the SDF1-3'A variant may be associated with an increased risk of laryngeal cancer.
Similar content being viewed by others
References
Sadri M, McMahon J, Parker A (2006) Management of laryngeal dysplasia. Eur Arch Otorhinolaryngol 263:843–852
Sapkota A, Hsu CC, Zaridze D et al (2008) Dietary risk factors for squamous cell carcinoma of the upper aerodigestive tract in central and eastern Europe. Cancer Causes Control 19:1161–1170
Freedman ND, Abnet CC, Leitzmann MF, Hollenbeck AR et al (2007) Prospective investigation of the cigarette smoking-head and neck cancer association by sex. Cancer 110:1593–1601
Szyfter K, Szmeja Z, Szyfter W et al (1999) Molecular and cellular alterations in tobacco smoke-associated larynx cancer. Mutat Res 445:259–274
Bradford CR (1999) Predictive factors in head and neck cancer. Hematol Oncol Clin North Am 13:777–785
Moser B, Loetscher P (2001) Lymphocyte traffic control by chemokines. Nat Immunol 2:123–128
Zlotnik A, Yoshie O (2000) Chemokines: a new classification system and their role in immunity. Immunity 12:121–127
Campbell JJ, Butcher E (2000) Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. Curr Opin Immunol 12:336–341
Balkwill F (2003) Chemokine biology in cancer. Sem Immunol 15:49–55
Zou YR, Kottmann AH, Kuroda M et al (1998) Function of the chemokine receptor CXCR4 in a heamatopoiesis and in cerebellar development. Nature 393:595–599
Onai N, Zhang Y, Yoneyama H et al (2008) Impairment of lymphopoiesis and myelopoiesis in mice reconstituted with bone marrow-hematopoietic progenitor cells expressing SDF-1-intrakine. Blood 96:2074–2080
Yasuoka H, Tsujimoto M, Yoshidome K et al (2008) Cytoplasmic CXCR4 expression in breast cancer: induction by nitric oxide and correlation with lymph node metastasis and poor prognosis. BMC Cancer 8:340
Kim J, Mori T, Chen SL et al (2006) Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome. Ann Surg 244:113–120
Maréchal R, Demetter P, Nagy N et al (2009) High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma. Br J Cancer 100:1444–1451
Kajiyama H, Shibata K, Terauchi M et al (2008) Involvement of SDF-1alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma. Int J Cancer 122:91–99
Akashi T, Koizumi K, Tsuneyama K et al (2008) Chemokine receptor CXCR4 expression and prognosis in patients with metastatic prostate cancer. Cancer Sci 99:539–542
Kijima T, Maulik G, Ma PC et al (2002) Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells. Cancer Res 62:6304–6311
Lee HJ, Kim SW, Kim HY et al (2009) Chemokine receptor CXCR4 expression, function, and clinical implications in gastric cancer. Int J Oncol 34:473–480
Oliveira-Neto HH, Silva ET, Leles CR et al (2008) Involvement of CXCL12 and CXCR4 in lymph node metastases and development of oral squamous cell carcinomas. Tumour Biol 29:262–271
Taki M, Higashikawa K, Yoneda S et al (2008) Up-regulation of stromal cell-derived factor-1alpha and its receptor CXCR4 expression accompanied with epithelial-mesenchymal transition in human oral squamous cell carcinoma. Oncol Rep 19:993–998
Winkler C, Modi W, Smith MW et al (1998) Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. Science 279:389–393
Watanabe MA, de Oliveira Cavassin GG, Orellana MD et al (2003) SDF-1 gene polymorphisms and syncytia induction in Brazilian HIV-1 infected individuals. Microb Pathog 35:31–34
Kimura R, Nishioka T, Ishida T (2003) The SDF1–G801A polymorphism is not associated with SDF1 gene expression in Epstein–Barr virus-transformed lymphoblastoid cells. Genes Immun 4:356–361
de Oliveira Cavassin GG, De Lucca FL, Delgado Andre N et al (2004) Molecular investigation of the stromal cell-derived factor-1 chemokine in lymphoid leukemia and lymphoma patients from Brazil. Blood Cells Mol Diseases 33:90–93
Razmkhah M, Talei AR, Doroudchi M et al (2004) Stromal cell-derived factor-1 (SDF-1) alleles and susceptibility to breast carcinoma. Cancer Lett 225:261–266
Razmkhah M, Doroudchi M, Ghayumi SM et al (2005) Stromal cell-derived factor-1 (SDF-1) gene and susceptibility of Iranian patients with lung cancer. Lung Cancer 49:311–315
Teng YH, Liu TH, Tseng HC et al (2009) Contribution of genetic polymorphisms of stromal cell-derived factor-1 and its receptor, CXCR4, to the susceptibility and clinicopathologic development of oral cancer. Head Neck. doi:10.1002/hed.21094
Khademi B, Razmkhah M, Erfani N et al (2008) SDF-1 and CCR5 genes polymorphism in patients with head and neck cancer. Pathol Oncol Res 14:45–50
Vairaktaris E, Vylliotis A, Spyridonodou S et al (2008) A DNA polymorphism of stromal-derived factor-1 is associated with advanced stages of oral cancer. Anticancer Res 28:271–275
Frazer KA, Ballinger DG, Cox DR et al (2007) A second generation human haplotype map of over 3.1 million SNPs. Nature 449:851–861
Shirozu M, Nakano T, Inazawa J et al (1995) Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene. Genomics 28:495–500
Zlotnik A (2006) Chemokines and cancer. Int J Cancer 119:2026–2029
Zlotnik A (2008) New insights on the role of CXCR4 in cancer metastasis. J Pathol 215:211–213
Bleul CC, Farzan M, Choe H et al (1996) The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382:829–833
Vlahakis SR, Villasis-Keever A, Gomez T et al (2002) G protein-coupled chemokine receptors induce both survival and apoptotic signaling pathways. J Immunol 169:5546–5554
Chang L, Karin M (2001) Mammalian MAP kinase signalling cascades. Nature 410:37–40
Daly AJ, McIlreavey L, Irwin CR (2008) Regulation of HGF and SDF-1 expression by oral fibroblasts–implications for invasion of oral cancer. Oral Oncol 44:646–651
Uchida D, Onoue T, Tomizuka Y et al (2007) Involvement of an autocrine stromal cell derived factor-1/CXCR4 system on the distant metastasis of human oral squamous cell carcinoma. Mol Cancer Res 5:685–694
Acknowledgements
Supported by a grant No 502-01-01124182-07474 Poznań University of Medical Sciences.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kruszyna, Ł., Lianeri, M., Rydzanicz, M. et al. SDF1-3'A Gene Polymorphism is Associated with Laryngeal Cancer. Pathol. Oncol. Res. 16, 223–227 (2010). https://doi.org/10.1007/s12253-009-9214-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12253-009-9214-5